Delivery Order SPE2DB25D7068-SPE2DB25FTWXH
- Not listed
- The Defense Logistics Agency awarded a $1,832.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ciprofloxacin-dexamethasone otic suspension in 7.5mL units. The award was made on June 27, 2025, with an ultimate completion date of June 30, 2025, and represents a non-set-aside competitive procurement. Performance will be executed from the company's Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and a key distribution hub for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) with a ceiling value of $1,074.73 under firm fixed pricing. This award, issued on November 3, 2025, represents a non-competitive set-aside delivery order with an ultimate completion date of November 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the point of performance for this pharmaceutical supply contract. This...
- The Defense Logistics Agency awarded a $1,097.53 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed price contract type. The award, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone otic suspension (7.5ml) valued at $5,275.58 under a firm fixed-price contract. The award, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This contract serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ml) under a firm fixed-price contract with a ceiling value of $1,900.20. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive delivery order without set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,594.26 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ciprofloxacin-dexamethasone otic suspension (7.5mL) with a ceiling value of $2,035.67 under a firm fixed-price contract type. The award was issued on July 14, 2025, with an ultimate completion date of July 15, 2025, and represents a non-competitive set-aside delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,780.32 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,451.13 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) on July 23, 2025, with completion scheduled for July 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) with a ceiling value of $4,619.58. This contract is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTWXHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ciprofloxacin-dexamethasone otic suspension (7.5ML) with a ceiling value of $1,569.12 under a firm fixed-price contract. The award was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive award. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract history demonstrates its capability to fulfill competitive federal procurement requirements across a wide spectrum of pharmaceutical products, ranging from specialty medications to generic drugs and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/2/25 |